Viking Therapeutics stock jumps on positive hip-fracture trial [MarketWatch]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: MarketWatch
Viking Therapeutics stock surges 18% premarket on positive trial of hip fracture treatment Shares of Viking Therapeutics Inc. VKTX, -2.27% surged 18% in premarket trade Tuesday, after the company announced positive results from a mid-stage trial of a treatment for hip fractures. The biotech, which is working to develop toherapies for metabolic and endocrine disorders, said the Phase 2 trial of its VK5211 program for muscle and bone disorders met its primary goal. "The study achieved statistical significance at all doses with a clear dose-response and, in our view, provides compelling evidence of VK5211's potent pharmacologic effect on muscle growth," Viking Chief Executive Brian Lian, Ph.D., said in a statement. Viking shares have gained 154% in 2017, while the S&P 500 SPX, -0.04% has gained 16%.
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics: An Oral Weight Loss Drug With More Data Ahead [Seeking Alpha]Seeking Alpha
- Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024PR Newswire
- Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- What Makes Viking Therapeutics (VKTX) an Attractive Potential Opportunity? [Yahoo! Finance]Yahoo! Finance
- Is it Too Late to Buy Viking Therapeutics Stock? [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/7/24 - In-Line
VKTX
Sec Filings
- 4/5/24 - Form ARS
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- VKTX's page on the SEC website